These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2831187)

  • 1. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.
    Lalazar A; Weisgraber KH; Rall SC; Giladi H; Innerarity TL; Levanon AZ; Boyles JK; Amit B; Gorecki M; Mahley RW
    J Biol Chem; 1988 Mar; 263(8):3542-5. PubMed ID: 2831187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
    Horie Y; Fazio S; Westerlund JR; Weisgraber KH; Rall SC
    J Biol Chem; 1992 Jan; 267(3):1962-8. PubMed ID: 1730728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human apolipoprotein E. Receptor binding activity of truncated variants with carboxyl-terminal deletions.
    Lalazar A; Mahley RW
    J Biol Chem; 1989 May; 264(15):8447-50. PubMed ID: 2542277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E.
    Raffai R; Maurice R; Weisgraber K; Innerarity T; Wang X; MacKenzie R; Hirama T; Watson D; Rassart E; Milne R
    J Lipid Res; 1995 Sep; 36(9):1905-18. PubMed ID: 8558079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor.
    Morrow JA; Arnold KS; Dong J; Balestra ME; Innerarity TL; Weisgraber KH
    J Biol Chem; 2000 Jan; 275(4):2576-80. PubMed ID: 10644716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity.
    Dong LM; Innerarity TL; Arnold KS; Newhouse YM; Weisgraber KH
    J Lipid Res; 1998 Jun; 39(6):1173-80. PubMed ID: 9643348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS; Fazio S; Mahley RW
    J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
    Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W
    J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.
    Dong LM; Wilson C; Wardell MR; Simmons T; Mahley RW; Weisgraber KH; Agard DA
    J Biol Chem; 1994 Sep; 269(35):22358-65. PubMed ID: 8071364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity.
    Wardell MR; Rall SC; Schaefer EJ; Kane JP; Weisgraber KH
    J Lipid Res; 1991 Mar; 32(3):521-8. PubMed ID: 1648586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.
    Pham T; Kodvawala A; Hui DY
    Biochemistry; 2005 May; 44(20):7577-82. PubMed ID: 15896001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E isoforms and lipoprotein metabolism.
    Phillips MC
    IUBMB Life; 2014 Sep; 66(9):616-23. PubMed ID: 25328986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand.
    Zaiou M; Arnold KS; Newhouse YM; Innerarity TL; Weisgraber KH; Segall ML; Phillips MC; Lund-Katz S
    J Lipid Res; 2000 Jul; 41(7):1087-95. PubMed ID: 10884290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.
    Futamura M; Dhanasekaran P; Handa T; Phillips MC; Lund-Katz S; Saito H
    J Biol Chem; 2005 Feb; 280(7):5414-22. PubMed ID: 15583000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.
    Wardell MR; Weisgraber KH; Havekes LM; Rall SC
    J Biol Chem; 1989 Dec; 264(35):21205-10. PubMed ID: 2556398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS; Fazio S; Lee YL; Mahley RW
    J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.
    Morrow JA; Arnold KS; Weisgraber KH
    Protein Expr Purif; 1999 Jul; 16(2):224-30. PubMed ID: 10419818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-ligand interaction between vitellogenin receptor (VtgR) and vitellogenin (Vtg), implications on low density lipoprotein receptor and apolipoprotein B/E. The first three ligand-binding repeats of VtgR interact with the amino-terminal region of Vtg.
    Li A; Sadasivam M; Ding JL
    J Biol Chem; 2003 Jan; 278(5):2799-806. PubMed ID: 12429745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E.
    Vogel T; Weisgraber KH; Zeevi MI; Ben-Artzi H; Levanon AZ; Rall SC; Innerarity TL; Hui DY; Taylor JM; Kanner D
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8696-700. PubMed ID: 3909150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.